Previously highlighted contents.
To Hit or Not to Hit, That Is the Question – Genome-wide Structure-Based Druggability Predictions for Pseudomonas aeruginosa Proteins
In 2014 Ruth was awared nearly 60,000 Euros over two years from the Gutenberg Lehrkolleg for research oriented teaching.
The Bio3D package includes new methods for the analysis and visualization of protein dynamics both from experimental and simulated data, integrated with tools for comparative analysis of evolutionary related protein structures and systematic retrieval of publicly available sequence and structural data.
The Research Council of Norway will fund 16 new research infrastructures. One of them is the Norwegian NMR Platform, which has been awarded 51.4 MNOK for new NMR equipment.
PhD candidate Helene J. Bustad from Biorecognition won the poster prize at this year's NBS Contact Meeting at Røros.
Researchers in Biorecognition recently published a potential therapy for the metabolic disorder methylamalonic aciduria in the journal Human Molecular Genetics.
High-throughput screening (HTS) is a method widely used in drug development, where liquid-handling robotics is combined with computational tools to test large number of samples for specific properties. We use HTS to find inhibitors and pharmacological chaperones for our proteins.
Dr. Lars Skjærven and Professor Aurora Martinez got their publication highlighted on the October issue of Proteins.
After getting an article accepted in FEBS Letters, the authors sent a cover art suggestion to the journal. The image was accepted and is featured on the cover of FEBS Lett., Volume 585, Issue 8.
During this years Health, Security, and Environment (HSE) meeting the Biorecognition group was awarded with the HSE prize for its contribtions.
